Michael Golembiewski - Jan 12, 2024 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Stock symbol
SEEL
Transactions as of
Jan 12, 2024
Transactions value $
$0
Form type
4
Date filed
1/17/2024, 09:47 PM
Previous filing
Dec 1, 2023
Next filing
Mar 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +24.5K $0.00 24.5K Jan 12, 2024 Common Stock 24.5K $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on January 12, 2025, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.